Piscaglia F - Search Results

1

VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.

Scartozzi M, Faloppi L, Svegliati Baroni G, Loretelli C, Piscaglia F, Iavarone M, Toniutto P, Fava G, De Minicis S, Mandolesi A, Bianconi M, Giampieri R, Granito A, Facchetti F, Bitetto D, Marinelli S, Venerandi L, Vavassori S, Gemini S, D'Errico A, Colombo M, Bolondi L, Bearzi I, Benedetti A, Cascinu S. Scartozzi M, et al. Among authors: piscaglia f. Int J Cancer. 2014 Sep 1;135(5):1247-56. doi: 10.1002/ijc.28772. Epub 2014 Feb 20. Int J Cancer. 2014. PMID: 24510746

2

Cigarette smoking, abdominal blood flow and abdominal diseases.

Bolondi L, Piscaglia F. Bolondi L, et al. Among authors: piscaglia f. J Gastroenterol Hepatol. 1996 Nov;11(11):995-6. doi: 10.1111/j.1440-1746.1996.tb00019.x. J Gastroenterol Hepatol. 1996. PMID: 8985814 No abstract available.

3

What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy.

Gaiani S, Gramantieri L, Venturoli N, Piscaglia F, Siringo S, D'Errico A, Zironi G, Grigioni W, Bolondi L. Gaiani S, et al. Among authors: piscaglia f. J Hepatol. 1997 Dec;27(6):979-85. doi: 10.1016/s0168-8278(97)80140-7. J Hepatol. 1997. PMID: 9453422 Clinical Trial.

4

Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.

Gramantieri L, Chieco P, Di Tomaso M, Masi L, Piscaglia F, Brillanti S, Gaiani S, Valgimigli M, Mazziotti A, Bolondi L. Gramantieri L, et al. Among authors: piscaglia f. Clin Cancer Res. 1999 Nov;5(11):3468-75. Clin Cancer Res. 1999. PMID: 10589760

5

Vascularity of liver tumours and recent advances in doppler ultrasound.

Gaiani S, Volpe L, Piscaglia F, Bolondi L. Gaiani S, et al. Among authors: piscaglia f. J Hepatol. 2001 Mar;34(3):474-82. doi: 10.1016/s0168-8278(01)00021-6. J Hepatol. 2001. PMID: 11322212 Review. No abstract available.

6

Review article: percutaneous treatment of hepatocellular carcinoma.

Gaiani S, Celli N, Cecilioni L, Piscaglia F, Bolondi L. Gaiani S, et al. Among authors: piscaglia f. Aliment Pharmacol Ther. 2003 Jun;17 Suppl 2:103-10. doi: 10.1046/j.1365-2036.17.s2.21.x. Aliment Pharmacol Ther. 2003. PMID: 12786621 Review.

7

Review article: liver transplantation for HCC. Treatment options on the waiting list.

Bolondi L, Piscaglia F, Camaggi V, Grazi GL, Cavallari A. Bolondi L, et al. Among authors: piscaglia f. Aliment Pharmacol Ther. 2003 Jun;17 Suppl 2:145-50. doi: 10.1046/j.1365-2036.17.s2.8.x. Aliment Pharmacol Ther. 2003. PMID: 12786626 Review.

8

Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.

Vivarelli M, Cucchetti A, Piscaglia F, La Barba G, Bolondi L, Cavallari A, Pinna AD. Vivarelli M, et al. Among authors: piscaglia f. Liver Transpl. 2005 May;11(5):497-503. doi: 10.1002/lt.20391. Liver Transpl. 2005. PMID: 15838913 Free article.

9

Management of small hepatocellular carcinoma.

Leoni S, Piscaglia F, Righini R, Bolondi L. Leoni S, et al. Among authors: piscaglia f. Acta Gastroenterol Belg. 2006 Apr-Jun;69(2):230-5. Acta Gastroenterol Belg. 2006. PMID: 16929622 Review.

10

The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations.

Piscaglia F, Bolondi L; Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. Piscaglia F, et al. Ultrasound Med Biol. 2006 Sep;32(9):1369-75. doi: 10.1016/j.ultrasmedbio.2006.05.031. Ultrasound Med Biol. 2006. PMID: 16965977

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

452 results

Search Page

Filters